Skip to content

Heidelberg Engineering ANTERION Software Comparison Study

The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06657716
Enrollment
60
Registered
2024-10-24
Start date
2024-10-02
Completion date
2026-11-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyes With Abnormal Anterior Segment, Eyes With Normal Anterior Segment

Brief summary

This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)

Interventions

Device: ANTERION investigational Measurements from the investigational device ANTERION with software version 1.5 are to be compared against measurements from the ANTERION with software version 1.2.4 (cleared version)

Sponsors

Heidelberg Engineering GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Normal Anterior Segment 1. Age 22 years or older 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions 3. Able to fixate 4. Eye(s) with normal anterior segment

Exclusion criteria

Normal Anterior Segment 1. Active infection or inflammation in the study eye 2. Insufficient tear film or corneal reflex 3. Physical inability to be properly positioned at the study devices or eye exam equipment 4. Rigid contact lens wear 2 weeks prior to imaging 5. Soft lenses worn within one hour prior to imaging 6. Cataract grade ≥1.5 Inclusion Criteria Abnormal Anterior Segment 1. Age 22 years or older 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions 3. Able to fixate 4. Eye(s) with abnormal anterior segment (including cataract grade ≥ 1.5)

Design outcomes

Primary

MeasureTime frameDescription
Central Cornea ThicknessThrough study completion, an average of 1 dayReproducibility and repeatability of Central Cornea Thickness of ANTERION and the reference device
Thinnest Point ThicknessThrough study completion, an average of 1 dayReproducibility and repeatability of Thinnest Point Thickness of ANTERION and the reference device
Lens ThicknessThrough study completion, an average of 1 dayReproducibility and repeatability of Lens Thickness of ANTERION and the reference device
Anterior Chamber DepthThrough study completion, an average of 1 dayReproducibility and repeatability of Anterior Chamber Depth of ANTERION and the reference device
Axial LengthThrough study completion, an average of 1 dayReproducibility and repeatability of Axial Length of ANTERION and the reference device

Secondary

MeasureTime frameDescription
Adverse Events RateThrough study completion, an average of 1 dayAdverse events found during the clinical study

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJeffrey Fischer, MD

Fischer Laser Eye Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026